Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Pan‐cancer analysis identifies...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment

Bibliographic Details
Main Authors: Tao Jiang, Qingzhu Jia, Wenfeng Fang, Shengxiang Ren, Xiaoxia Chen, Chunxia Su, Li Zhang, Caicun Zhou
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Clinical and Translational Medicine
Subjects:
biomarker
immune checkpoint inhibitors
immune microenvironment
TERT
Online Access:https://doi.org/10.1002/ctm2.109
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1002/ctm2.109

Similar Items

  • TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas
    by: Feng Tang, et al.
    Published: (2023-08-01)
  • The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
    by: Patrizia Leone, et al.
    Published: (2021-05-01)
  • Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma
    by: Qi Wang, et al.
    Published: (2023-10-01)
  • Targeting T-cell metabolism to boost immune checkpoint inhibitor therapy
    by: Haohao Li, et al.
    Published: (2022-12-01)
  • PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types
    by: Xiaoling Shang, et al.
    Published: (2022-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs